Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Poly(I:C) | 2 | ug/mL | 1 | IL-7 | 22.0 | 51 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL-7 | 11.0 | 48 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | IL-7 | 13.0 | 50 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL-7 | 21.0 | 75 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | IL-7 | 18.0 | 57 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL-7 | 12.0 | 39 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | IL-7 | 13.0 | 25 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL-7 | 13.0 | 41 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | IL-7 | 16.0 | 48 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | IL-7 | 10.0 | 43 | ||||
RA1869 | 1 | IL-7 | 10.0 | 44 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | IL-7 | 24.0 | 38 | ||||
N2759 | 1 | IL-7 | 24.0 | 45 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | IL-7 | 11.5 | 44 | ||||
RA1931 | 1 | IL-7 | 15.0 | 43 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | IL-7 | 14.0 | 53 | ||||
N2586 | 1 | IL-7 | 16.0 | 59 | |||||||
0 | IL-7 | 10.0 | 45 | ||||||||
0 | IL-7 | 10.0 | 71 | ||||||||
0 | IL-7 | 8.0 | 61 | ||||||||
0 | IL-7 | 10.0 | 49 | ||||||||
0 | IL-7 | 8.0 | 49 | ||||||||
0 | IL-7 | 10.0 | 48 | ||||||||
RA2159 | 2 | IL-7 | 34.0 | 60 | |||||||
N2645 | 2 | IL-7 | 12.0 | 72 |